The 10 Scariest Things About ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during pregnancy and breastfeeding is a challenge for women suffering from the condition. There isn't much information on how long-term exposure to these medications may affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological disorders such as hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication should weigh the benefits of taking it versus the risks to the fetus. Doctors don't have the data needed to give clear guidelines however they can provide information regarding the risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy were not at higher risk of fetal malformations or structural birth defects. Researchers conducted a massive population-based study of case control to examine the prevalence of major structural defects in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure accurate classification of the cases and to reduce the chance of bias.

However, the researchers' study had its limitations. In particular, they were not able to differentiate the effects of the medication from the disorder that is underlying. This makes it difficult to determine whether the small differences observed in the exposed groups are due to medication use or comorbidities that cause confusion. In addition the researchers did not examine long-term offspring outcomes.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at a more risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders, and the increased risk of admission was not found to be influenced by the stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during the early stages of pregnancy could be offset by the greater benefit for both mother and child from continued treatment for the woman's disorder. Physicians should discuss this with their patients and, where to get prescribed adhd medication possible, help them develop strategies to improve coping skills which can reduce the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop it during pregnancy as more women are diagnosed with ADHD. Most of the time, these decisions are made without solid and reliable evidence regardless, so doctors must weigh their knowledge about their experiences, the experiences of other doctors, and what the research suggests on the subject as well as their own judgments for each patient.

The issue of possible risks to infants is difficult to determine. Many studies on this issue are based on observations rather than controlled research, and their conclusions are often contradictory. Most studies limit their analysis to live-births, which could underestimate the teratogenic impact that can lead to terminations or abortions of pregnancy. The study that is discussed in this journal club addresses these shortcomings by examining data on both live and deceased births.

Conclusion: While some studies have revealed an association between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. Most studies show a neutral, or even somewhat negative, impact. Therefore an accurate risk-benefit analysis is required in every instance.

It can be challenging, if not impossible, for women with ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. Additionally, the loss of medication can affect the ability to perform work-related tasks and safely drive which are essential aspects of daily life for a lot of people with ADHD.

She recommends women who are uncertain about whether or not to discontinue medication due to their pregnancy should consider educating family members, friends and colleagues on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment plan. Educating them can also make the woman feel more comfortable when she is struggling with her decision. It is important to note that certain medications are able to pass through the placenta, so if a woman decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that the effects of the drug can be transferred to the infant.

Risk of Birth Defects

As the use and abuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the possible effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers used two massive datasets to analyze over 4.3 million pregnant women and determine if the use of stimulant medications increased birth defects. Researchers discovered that although the overall risk is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The researchers of the study found no link between the use of early medications and congenital abnormalities like facial clefting, or club foot. The results are in line with previous studies revealing an increase, but not significant, in the risk of heart malformations in women who started taking adhd Inattentive Type medication medications prior to the time of pregnancy. The risk increased in the latter part of pregnancy when a large number of women began to stop taking their medication.

Women who took adhd medication guide medications during the first trimester of their pregnancy were also more likely to have caesarean sections, a low Apgar score following delivery, and a baby who required breathing assistance at birth. The authors of the study were not able to eliminate bias due to selection because they restricted the study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope their research will inform physicians when they encounter pregnant women. The researchers advise that, while discussing benefits and risks are crucial, the decision regarding whether or not to stop medication should be made based on the severity of each woman's ADHD symptoms and her needs.

The authors also warn that while discontinuing the medications is an option, it isn't an option that is recommended due to the high prevalence of depression and other mental health issues in women who are pregnant or who are recently post-partum. Additionally, research suggests that women who stop taking their medication will have a difficult transitioning to life without them once the baby is born.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD may face a lot of challenges when they must manage their symptoms, go to doctor appointments and prepare for the birth of a child and adjust to a new routine. This is why many women decide to continue taking their ADHD medications throughout the course of pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at a low level. However, the rate of medication exposure to the newborn may differ based on dosage, how often it is administered and at what time the medication is administered. In addition, different drugs enter the infant's system via the gastrointestinal tract, or through breast milk. The effect on the health of a newborn is not completely comprehended.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the lack of research. It is a difficult decision for the woman who must weigh the advantages of her medication against the risks to the foetus. As long as more information is available, doctors can ask pregnant patients if they have any background of ADHD or if they intend to take medication in the perinatal period.

A increasing number of studies have revealed that the majority of women are able to safely continue taking their adhd medication guide medication while they are pregnant and nursing. As a result, an increasing number of patients opt to do this and, after consulting with their doctor, they have found that the benefits of maintaining their current medication outweigh any potential risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD recognize the signs and the underlying disorder. They should also learn about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary effort including obstetricians, GPs, and psychiatry. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration and, if needed adjustments to the medication regimen.